PDS Biotechnology Corpora... (PDSB)
1.15
0.07 (6.48%)
At close: Apr 02, 2025, 3:59 PM
1.14
-0.52%
After-hours: Apr 02, 2025, 07:55 PM EDT
PDS Biotechnology Income Statement
Financials in USD. Fiscal year
is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | n/a | 57.33K | 49.08K | 246.39K | 176.29K | 98.41K | 69.12K | 182.92K | 100.12K | 53.12K | n/a | n/a | 2.18K |
| Gross Profit | n/a | -57.33K | -49.08K | -246.39K | -176.29K | -98.41K | -69.12K | -182.92K | -100.12K | -53.12K | n/a | n/a | -2.18K |
| Operating Income | -36.32B | -43.05M | -41.67M | -21.44M | -14.9M | -21.03M | -43.1M | -51.97M | -39.51M | -26.5M | -13.19M | -6.49M | -4.69M |
| Interest Income | 2.51B | 2.9M | 935.18K | 4.35K | 55.01K | 353.49K | 871.88K | 700.9K | 212.3K | 9.08K | 2.94K | 3.95K | 1.94K |
| Pretax Income | -38.48B | -44.35M | -42.05M | -21.43M | -14.85M | -7.38M | -43.65M | -53.45M | -40.67M | -29.19M | -12.79M | -7.34M | -4.7M |
| Net Income | -39.35B | -42.94M | -40.85M | -16.92M | -14.85M | -7M | -40.87M | -50.86M | -38.82M | -28.08M | -12.2M | -6.88M | -4.7M |
| Selling & General & Admin | 13.76B | 15.28M | 12.24M | 10.18M | 6.96M | 10.98M | 14.29M | 17.65M | 14.69M | 8.66M | 4.72M | 2M | 980.51K |
| Research & Development | 22.57B | 27.76M | 29.43M | 11.25M | 7.92M | 6.1M | 16.07M | 34.31M | 24.83M | 17.84M | 8.47M | 4.48M | 3.71M |
| Other Expenses | n/a | 0.00 | n/a | n/a | 15.61K | 3.95B | 12.74B | n/a | -163.46K | -1.88M | n/a | n/a | n/a |
| Operating Expenses | 36.32B | 43.05M | 41.67M | 21.44M | 14.9M | 17.08M | 30.36M | 51.97M | 39.51M | 26.5M | 13.19M | 6.49M | 4.69M |
| Interest Expense | -4.67B | 4.21M | 1.32M | n/a | n/a | 33.56K | 1.43M | 2.18M | 1.2M | 816.49K | 183.18K | 3.35K | 2.65K |
| Selling & Marketing Expenses | n/a | 264K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | n/a | 43.05M | 41.67M | 21.44M | 14.9M | 17.08M | 30.36M | 51.97M | 39.51M | 26.5M | 13.19M | 6.49M | 4.69M |
| Income Tax | 869.17M | -1.41M | -1.2M | -4.52M | -135.68K | -381.51K | -2.78M | -2.59M | -1.85M | -1.11M | -590.67K | -459.02K | n/a |
| Shares Outstanding (Basic) | 36.45M | 30.95M | 28.6M | 25.6M | 16.75M | 4.87M | 1.56M | 1.52M | 1.44M | 404.4K | 755.36K | 755.36K | 1.43M |
| Shares Outstanding (Diluted) | 36.45M | 30.95M | 28.6M | 25.6M | 16.75M | 4.87M | 1.56M | 1.52M | 1.44M | 404.4K | 755.36K | 755.36K | 1.43M |
| EPS (Basic) | -1.08K | -1.39 | -1.43 | -0.66 | -0.89 | -1.44 | -26.16 | -33.47 | -26.9 | -69.43 | -16.15 | -9.11 | -3.3 |
| EPS (Diluted) | -1.08K | -1.39 | -1.43 | -0.66 | -0.89 | -1.44 | -26.16 | -33.47 | -26.9 | -69.43 | -16.15 | -9.11 | -3.3 |
| EBITDA | -36.32B | -40.08M | -41.62M | -21.19M | -14.67M | -7.25M | -3.58M | -51.08M | -39.36M | -28.32M | -13.16M | -6.48M | -4.69M |
| EBIT | -43.15B | -40.14M | -40.74M | -21.43M | -14.85M | -17.08M | -3.83M | -51.27M | -39.46M | -28.37M | -12.61M | -7.34M | -4.7M |
| Depreciation & Amortization | n/a | 57.33K | 49.08K | 246.39K | 176.29K | 98.41K | 69.12K | 182.92K | 100.12K | 53.12K | 31.23K | 4.44K | 2.18K |